EP Patent

EP0413533A1 — Microencapsulated taste-masked water-insoluble NSAID drug materials

Assigned to Adare Pharma Solutions Inc · Expires 1991-02-20 · 35y expired

What this patent protects

This disclosure is directed to preparation of individual taste-masked, high payload, microcapsules by microencapsulation of water-insoluble NSAID drug materials in the substantial absence of microcapsule agglomerates. These taste-masked microcapsules contain a high payload, e.g. …

USPTO Abstract

This disclosure is directed to preparation of individual taste-masked, high payload, microcapsules by microencapsulation of water-insoluble NSAID drug materials in the substantial absence of microcapsule agglomerates. These taste-masked microcapsules contain a high payload, e.g. at least 83+ wt.% of said NSAID drug material and can then be formulated into chewable tablets and liquid aqueous suspensions for medicinal use. Cellulose acetate phthalate is the micro-encapsulating polymer wall material. Control of pH, controlled addition of a Hofmeister (lyotropic), salt, microencapsulation of the water-insoluble NSAID medicament with a liquid phase of cellulose acetate phthalate microencapsulating material and the subsequent insolubilization of said liquid encapsulating material after it is wrapped around the medicament core with dilute acid are important process parameters to achieving the proper individual microcapsules to obtain taste-masked, water insoluble NSAID drug materials, esp., naproxen and ibuprofen, by microencapsulation alone.

Drugs covered by this patent

Patent Metadata

Patent number
EP0413533A1
Jurisdiction
EP
Classification
Expires
1991-02-20
Drug substance claim
No
Drug product claim
No
Assignee
Adare Pharma Solutions Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.